Inhibitor Therapeutics (INTI) Return on Assets (2013 - 2026)
Inhibitor Therapeutics' (INTI) quarterly Return on Assets came in at 0.02% in Q1 2026, down 1.0% YoY from 0.02% in Q1 2025, and down 53.51% on a QoQ basis from 0.01% in Q4 2025.
Inhibitor Therapeutics (INTI) Return on Assets (2013 - 2026) Analysis & Trends
Inhibitor Therapeutics (INTI) has 14 years of Return on Assets data on file, last reported at 0.02% in Q1 2026.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (down 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets declined to 0.02% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2023 to a low of 0.06% in Q3 2022.
- A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets fell 2 bps — and 2023, when it grew 5 bps.
- Tracing INTI's Return on Assets over 5 years: stood at 0.0% in 2022, then sank by 201 bps to 0.0% in 2023, then plunged by 74 bps to 0.01% in 2024, then slumped by 101 bps to 0.01% in 2025, then plunged by 54 bps to 0.02% in 2026.
- The last three Return on Assets figures came in at 0.02% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Inhibitor Therapeutics | 15.64 Mn | 15.64 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -0.06% |
| Mar 31, 2022 | -0.04% |
| Dec 31, 2021 | -0.04% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -0.04% |